Human Papillomavirus Type 18 L1Protein
Cervical carcinoma, Human papillomavirus infections.
How it works
Human Papillomavirus (HPV) type 16 and 18 cause about 70% of cervical cancer. HPV bivalent (types 16 and 18) vaccine is a non-infectious vaccine produced by recombinant technology, which contains virus-like particles (VLP) of the major capsid L1 protein of oncogenic HPV types 16 and 18. Efficacy of vaccine may be mediated by the production of IgG neutralizing antibodies against the HPV-L1 capsid proteins.
Common side effects
Dizziness, Fever, Injection site redness, Injection site soreness, Itching, Nausea, Swelling